pridinol
This page covers all pridinol drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Muscarinic acetylcholine receptor M1, Muscarinic acetylcholine receptor M2, Muscarinic acetylcholine receptor M3.
Targets
Phase 2 pipeline (1)
- PRIDINOL · Neuroscience
Pridinol works by binding to the muscarinic acetylcholine receptor M1, which helps to relax muscles and reduce muscle spasms.
Patent intelligence
- pridinol patent landscape — aggregated cliff calendar, attackable patents, originator estates